BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22402599)

  • 1. Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model.
    Li N; Zheng D; Wei X; Jin Z; Zhang C; Li K
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1131-44. PubMed ID: 22402599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma.
    Huang G; Chen L
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1201-11. PubMed ID: 20130910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.
    Peng F; Xu Z; Wang J; Chen Y; Li Q; Zuo Y; Chen J; Hu X; Zhou Q; Wang Y; Ma H; Bao Y; Chen M
    PLoS One; 2012; 7(4):e34646. PubMed ID: 22496834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the effect of rh-endostatin on intratumoral and myocardial micrangium in mice].
    Zhang CC; Li K; Wei XY; Chen C; Yuan J; Wang J
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):415-20. PubMed ID: 21875480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of circulating endothelial cells for efficacy of chemotherapy with Rh-endostatin in non-small cell lung cancer.
    Liu ZJ; Wang J; Wei XY; Chen P; Wang LC; Lin L; Sun BC; Li K
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):927-37. PubMed ID: 22331237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of recombinant human endostatin and docetaxel on MMP and its following anti-neoplastic effect under different administration sequences].
    Yuan J; Li K
    Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):580-5. PubMed ID: 20681443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549.
    Li ZY; Zhu F; Hu JL; Peng G; Chen J; Zhang S; Chen X; Zhang RG; Chen LJ; Liu P; Luo M; Sun ZH; Ren JH; Huang LL; Wu G
    Tumour Biol; 2011 Aug; 32(4):677-87. PubMed ID: 21442281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine.
    Wu Y; Yang L; Hu B; Liu JY; Su JM; Luo Y; Ding ZY; Niu T; Li Q; Xie XJ; Wen YJ; Tian L; Kan B; Mao YQ; Wei YQ
    Anticancer Drugs; 2005 Jun; 16(5):551-7. PubMed ID: 15846121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Observation of the antitumor effect of endostar combined with docetaxel under different administration sequences].
    Yuan J; Wu CW; Liu ZJ; Wei XY; Li K
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):580-5. PubMed ID: 21122408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo.
    Nilsson UW; Dabrosin C
    Cancer Res; 2006 May; 66(9):4789-94. PubMed ID: 16651433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism.
    Du Z; Hou S
    J Urol; 2003 Nov; 170(5):2000-3. PubMed ID: 14532841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models.
    Shi S; Wang R; Chen Y; Song H; Chen L; Huang G
    PLoS One; 2013; 8(6):e65757. PubMed ID: 23799045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia.
    Zhu H; Yang X; Ding Y; Liu J; Lu J; Zhan L; Qin Q; Zhang H; Chen X; Yang Y; Yang Y; Liu Z; Yang M; Zhou X; Cheng H; Sun X
    Sci Rep; 2015 Sep; 5():14503. PubMed ID: 26412785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer.
    Wang R; Qin S; Chen Y; Li Y; Chen C; Wang Z; Zheng R; Wu Q
    Oncol Rep; 2012 Aug; 28(2):439-45. PubMed ID: 22641525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugation of gold nanoparticles and recombinant human endostatin modulates vascular normalization via interruption of anterior gradient 2-mediated angiogenesis.
    Pan F; Yang W; Li W; Yang XY; Liu S; Li X; Zhao X; Ding H; Qin L; Pan Y
    Tumour Biol; 2017 Jul; 39(7):1010428317708547. PubMed ID: 28714365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical observation and therapeutic evaluation of Rh-endostatin combined with DP regimen in treating patients with advanced esophageal cancer.
    Deng WY; Song T; Li N; Luo SX; Li X
    Asian Pac J Cancer Prev; 2014; 15(16):6565-70. PubMed ID: 25169488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the anti-angiogenic effect of endostatin/cyclophosphamide to normalize tumor micrangium through notch signaling pathway in colon cancer.
    Lv JY; Hu TY; Wang RY; Zhu JM; Wang G
    World J Surg Oncol; 2016 Jan; 14(1):10. PubMed ID: 26762567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].
    Wu Y; Yang L; Zhao X; Su JM; Hu B; Liu JY; Niu T; Luo Y; Li Q; Wei YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):557-61. PubMed ID: 15583981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancies between antiangiogenic and antitumor effects of recombinant human endostatin.
    Huang G; Chen L
    Cancer Biother Radiopharm; 2009 Oct; 24(5):589-96. PubMed ID: 19877889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of rh-endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh-endostatin plus pemetrexed maintenance in non-small cell lung cancer: A retrospective comparison with standard chemotherapy.
    Zhou S; Zuo L; He X; Pi J; Jin J; Shi Y
    Thorac Cancer; 2018 Nov; 9(11):1354-1360. PubMed ID: 30152052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.